Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Arrowhead Pharma
(NQ:
ARWR
)
21.98
+0.11 (+0.52%)
Streaming Delayed Price
Updated: 9:31 AM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Arrowhead Pharma
< Previous
1
2
3
4
5
Next >
The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024
April 05, 2024
With risk-on sentiment in place, investors may be looking for the most undervalued Russell 2000 stocks to buy in April.
Via
InvestorPlace
NetApp, Zoom Video And 2 Other Stocks Insiders Are Selling
April 04, 2024
The Nasdaq 100 closed higher by around 0.2% on Wednesday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
March 13, 2024
With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.
Via
InvestorPlace
The 3 Most Undervalued Russell 2000 Stocks to Buy in March 2024
March 11, 2024
The Russell 2000 is up about 4% year to date, and could push higher, taking the most undervalued Russell 2000 stocks along for the ride.
Via
InvestorPlace
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
March 11, 2024
U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Cracking The Code: Understanding Analyst Reviews For Arrowhead Pharma
February 07, 2024
Via
Benzinga
Recap: Arrowhead Pharma Q1 Earnings
February 06, 2024
Via
Benzinga
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
March 01, 2024
U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
7 Oversold Russell 2000 Stocks to Add to Your February Buy List
February 25, 2024
Investors may want to jump into oversold Russell 2000 stocks. After a rough outing in 2023, many are starting to come back strong.
Via
InvestorPlace
Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.
February 23, 2024
Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy.
Via
Investor's Business Daily
Earnings Scheduled For February 6, 2024
February 06, 2024
Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion.
Via
Benzinga
4 Analysts Assess Arrowhead Pharma: What You Need To Know
January 02, 2024
Via
Benzinga
What 4 Analyst Ratings Have To Say About Arrowhead Pharma
December 04, 2023
Via
Benzinga
Recap: Arrowhead Pharma Q4 Earnings
November 29, 2023
Via
Benzinga
7 Biotech Stocks Fighting America’s Deadliest Diseases
February 08, 2024
Although the human condition can be alarmingly frail at times, these groundbreaking biotech stocks are aiming to right the ship.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 06, 2024
Via
Benzinga
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
January 05, 2024
Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.
Via
Investor's Business Daily
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
January 04, 2024
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Outlook For Arrowhead Pharma
November 28, 2023
Via
Benzinga
Analyst Expectations for Arrowhead Pharma's Future
September 19, 2023
Via
Benzinga
Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 03, 2024
Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating on the stock.
Via
Benzinga
Why Arrowhead Pharmaceuticals Shares Are Moving
January 03, 2024
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) shares are trading higher by 5.4% to $32.68, gaining after initially falling, after the company priced an underwritten registered offering of about 15.79...
Via
Benzinga
TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday
January 03, 2024
U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during Wednesday’s session after it disclosed receiving a...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Analyst Ratings for Arrowhead Pharma
August 08, 2023
Via
Benzinga
Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback
December 29, 2023
Piper Sandler sees potential turnaround for Biotech sector in 2024, identifies thee top stocks; Arrowhead, Legend Biotech & Alnylam Pharmaceuticals.
Via
Benzinga
Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 30, 2023
Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results.
Via
Benzinga
Earnings Scheduled For November 29, 2023
November 29, 2023
Companies Reporting Before The Bell • CollPlant Biotechnologies (NASDAQ:CLGN) is likely to report quarterly loss at $0.13 per share on revenue of $3.50 million.
Via
Benzinga
Johnson & Johnson Offloads Rights For Hepatitis B Candidate To GSK
October 31, 2023
GSK plc (NYSE: GSK) and Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) have
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023
September 19, 2023
Via
Benzinga
Cramer Says 'Please Stay Away' From This EV Maker, It 'Should Not Be Public'
September 08, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Norfolk Southern Corporation (NYSE: NSC) is the "cheapest I’ve seen in a very long time,
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.